Literature DB >> 3537614

Adverse reactions and interactions with newer cephalosporin and cephamycin antibiotics.

S R Norrby.   

Abstract

In this review, adverse reactions and interactions associated with the use of the newer cephalosporins and cephamycins are surveyed; special emphasis is placed on those reactions specific for some of these newer agents, namely disulfiram-like reactions with alcohol, effects on prothrombin synthesis, and lower gastrointestinal tract reactions. It is apparent that cephalosporins with a 3-methylthiotetrazole side-chain in the cephem nucleus cause clinically significant side effects more frequently than those without such a moiety. While still having a high degree of safety, cephalosporins with this chemical structure clearly have a higher degree of toxicity than those without this side-chain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3537614     DOI: 10.1007/BF03259826

Source DB:  PubMed          Journal:  Med Toxicol        ISSN: 0112-5966


  75 in total

1.  Cephaloridine, cephalothin and the kidney.

Authors:  R D Foord
Journal:  J Antimicrob Chemother       Date:  1975       Impact factor: 5.790

2.  Interaction between cephalosporins and alcohol.

Authors:  H Portier; J M Chalopin; M Freysz; Y Tanter
Journal:  Lancet       Date:  1980-08-02       Impact factor: 79.321

3.  [A new cause of acute avitaminosis K: lamoxactam].

Authors:  F Brivet; M Dreyfus; F Bridey; S Naveau; M Samsonetti; B Herer
Journal:  Gastroenterol Clin Biol       Date:  1983-11

4.  Cefoxitin-associated exfoliative dermatitis.

Authors:  K J Tietze; J A Gaska
Journal:  Clin Pharm       Date:  1983 Nov-Dec

5.  On the disulfiram-like activity of moxalactam.

Authors:  R M Elenbaas; J L Ryan; W A Robinson; M J Singsank; M J Harvey; C D Klaassen
Journal:  Clin Pharmacol Ther       Date:  1982-09       Impact factor: 6.875

6.  Coagulopathy associated with broad spectrum antibiotic therapy.

Authors:  A W Lee; W H Proudfoot; W O Griffen
Journal:  J Ky Med Assoc       Date:  1983-06

7.  Antibiotic-associated colitis during moxalactam therapy.

Authors:  R W Tofte
Journal:  J Antimicrob Chemother       Date:  1981-04       Impact factor: 5.790

8.  Studies on the epidemiology of adverse drug reactions. II. An evaluation of penicillin allergy.

Authors:  J W Smith; J E Johnson; L E Cluff
Journal:  N Engl J Med       Date:  1966-05-05       Impact factor: 91.245

9.  [Effects of cephem antibiotics on ethanol metabolism].

Authors:  K Nakamura; A Nakagawa; M Tanaka; H Masuda; Y Hayashi; K Saionji
Journal:  Nihon Yakurigaku Zasshi       Date:  1984-02

10.  Penicillin allergy: clinical experience with a battery of skin-test reagents.

Authors:  G O Solley; G J Gleich; R G Van Dellen
Journal:  J Allergy Clin Immunol       Date:  1982-02       Impact factor: 10.793

View more
  7 in total

Review 1.  Antibacterial-induced nephrotoxicity in the newborn.

Authors:  V Fanos; L Cataldi
Journal:  Drug Saf       Date:  1999-03       Impact factor: 5.606

2.  Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole.

Authors:  J A Bosso; R A Prince
Journal:  Tex Heart Inst J       Date:  1990

3.  [Effectiveness and tolerance of cefixime in the treatment of acute pyelonephritis].

Authors:  L Weissbach; A Segal; K Tröster
Journal:  Infection       Date:  1990       Impact factor: 3.553

Review 4.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

Review 5.  Antibiotics in neonatal infections: a review.

Authors:  V Fanos; A Dall'Agnola
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

Review 6.  Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use.

Authors:  G L Kearns; R A Young
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

7.  Synergy and Mode of Action of Ceftazidime plus Quercetin or Luteolin on Streptococcus pyogenes.

Authors:  Supatcharee Siriwong; Kanjana Thumanu; Tanaporn Hengpratom; Griangsak Eumkeb
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-21       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.